Azilsartan/chlorthalidone combination therapy for blood pressure control
Judy WM ChengMassachusetts College of Pharmacy and Health Sciences, Brigham and Women's Hospital, Boston, MA, USABackground: Edarbyclor® is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-05-01
|
| Series: | Integrated Blood Pressure Control |
| Online Access: | http://www.dovepress.com/azilsartanchlorthalidone-combination-therapy-for-blood-pressure-contro-a13153 |